The present invention relates to certain novel pyridin compounds of Formula (I) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-thrombotic agents etc, and processes for their preparation, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.
Optimization of pyridylpiperazine-based inhibitors of the Escherichia coli AcrAB-TolC efflux pump
作者:Nina Compagne、Juan-Carlos Jiménez-Castellanos、Virginie Meurillon、Elizabeth Pradel、Anais Vieira Da Cruz、Catherine Piveteau、Alexandre Biela、Maxime Eveque、Florence Leroux、Benoit Deprez、Nicolas Willand、Ruben C. Hartkoorn、Marion Flipo
DOI:10.1016/j.ejmech.2023.115630
日期:2023.11
NOVEL PYRIDINE COMPOUNDS
申请人:AstraZeneca AB
公开号:EP1836189A1
公开(公告)日:2007-09-26
[EN] NOVEL PYRIDINE COMPOUNDS<br/>[FR] NOUVEAUX COMPOSES DE PYRIDINE
申请人:ASTRAZENECA AB
公开号:WO2006073361A1
公开(公告)日:2006-07-13
[EN] The present invention relates to certain novel pyridin compounds of Formula ( I ) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, and processes for their preparation, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them. [FR] La présente invention concerne certains nouveaux composés de pyridine de formule (I); des méthodes de préparation desdits composés, leur utilisation comme inhibiteurs de P2Y12 ou comme agents thrombotiques, etc. Elle concerne également des méthodes de préparation et d'utilisation desdits composés comme médicaments dans des maladies cardiovasculaires; ainsi que des compositions pharmaceutiques contenant ces composés.